Sio Capital Management as of June 30, 2025
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 52 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maximus (MMS) | 14.7 | $39M | 548k | 70.20 | |
| Disc Medicine (IRON) | 5.8 | $15M | 285k | 52.96 | |
| Globus Med Cl A (GMED) | 5.5 | $15M | 246k | 59.02 | |
| Centene Corporation (CNC) | 5.4 | $14M | 263k | 54.28 | |
| Merck & Co (MRK) | 5.3 | $14M | 174k | 79.16 | |
| Bright Minds Biosciences Com New (DRUG) | 5.1 | $13M | 512k | 26.11 | |
| Neurocrine Biosciences (NBIX) | 4.8 | $13M | 101k | 125.69 | |
| BioMarin Pharmaceutical (BMRN) | 4.7 | $12M | 225k | 54.97 | |
| Annexon (ANNX) | 3.8 | $9.8M | 4.1M | 2.40 | |
| IDEXX Laboratories Put Option (IDXX) | 3.7 | $9.7M | 18k | 536.34 | |
| Sanofi Sponsored Adr (SNY) | 3.5 | $9.1M | 188k | 48.31 | |
| Tyra Biosciences (TYRA) | 3.0 | $7.8M | 810k | 9.57 | |
| Biosante Pharmaceuticals (ANIP) | 2.8 | $7.4M | 113k | 65.25 | |
| Edgewise Therapeutics (EWTX) | 2.7 | $7.1M | 540k | 13.11 | |
| Anteris Technologies Global (AVR) | 2.7 | $7.0M | 1.8M | 3.79 | |
| Septerna (SEPN) | 2.4 | $6.2M | 584k | 10.57 | |
| CryoLife (AORT) | 1.9 | $4.9M | 159k | 31.10 | |
| Dianthus Therapeutics (DNTH) | 1.7 | $4.4M | 236k | 18.63 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.6 | $4.2M | 2.1M | 2.04 | |
| Pmv Pharmaceuticals (PMVP) | 1.5 | $4.0M | 3.7M | 1.06 | |
| Halyard Health (AVNS) | 1.4 | $3.5M | 289k | 12.24 | |
| Merus N V (MRUS) | 1.3 | $3.3M | 63k | 52.60 | |
| Aquestive Therapeutics (AQST) | 1.2 | $3.1M | 948k | 3.31 | |
| Inmune Bio Ord Put Option (INMB) | 1.1 | $3.0M | 1.3M | 2.31 | |
| Ventyx Biosciences (VTYX) | 1.1 | $2.8M | 1.3M | 2.14 | |
| Mbx Biosciences (MBX) | 1.1 | $2.7M | 241k | 11.41 | |
| Ideaya Biosciences (IDYA) | 1.0 | $2.6M | 124k | 21.02 | |
| Aligos Therapeutics Com New (ALGS) | 0.9 | $2.4M | 336k | 7.21 | |
| Vir Biotechnology (VIR) | 0.9 | $2.4M | 478k | 5.04 | |
| Neuroone Med Technologies Com New (NMTC) | 0.9 | $2.4M | 3.5M | 0.68 | |
| Senseonics Hldgs (SENS) | 0.9 | $2.3M | 4.9M | 0.48 | |
| Travere Therapeutics (TVTX) | 0.7 | $1.8M | 122k | 14.80 | |
| Erasca (ERAS) | 0.7 | $1.7M | 1.4M | 1.27 | |
| Astria Therapeutics (ATXS) | 0.7 | $1.7M | 318k | 5.36 | |
| Savara (SVRA) | 0.6 | $1.7M | 727k | 2.28 | |
| Enanta Pharmaceuticals (ENTA) | 0.5 | $1.4M | 179k | 7.56 | |
| Tela Bio (TELA) | 0.5 | $1.2M | 636k | 1.94 | |
| Alector (ALEC) | 0.5 | $1.2M | 846k | 1.40 | |
| Context Therapeutics (CNTX) | 0.3 | $879k | 1.3M | 0.66 | |
| Ovid Therapeutics (OVID) | 0.3 | $736k | 2.2M | 0.33 | |
| Modular Med Com New (MODD) | 0.2 | $585k | 786k | 0.74 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $578k | 123k | 4.70 | |
| Aprea Therapeutics Com New (APRE) | 0.2 | $472k | 279k | 1.69 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $380k | 51k | 7.48 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $360k | 72k | 4.99 | |
| Embecta Corp Common Stock (EMBC) | 0.1 | $302k | 31k | 9.69 | |
| Boundless Bio (BOLD) | 0.1 | $165k | 164k | 1.01 | |
| Nextcure (NXTC) | 0.0 | $60k | 131k | 0.46 | |
| Terns Pharmaceuticals (TERN) | 0.0 | $38k | 10k | 3.73 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $19k | 50k | 0.38 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $14k | 400k | 0.03 | |
| Atyr Pharma Com New Put Option (ATYR) | 0.0 | $5.6k | 1.1k | 5.07 |
